Home NDC 71610-815 BRILINTA
Product NDC 71610-815
11-digit product format 716100815
Labeler code 71610
Product ID 71610-815_159d6ad1-edcf-d4da-e063-6294a90a6adb
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ticagrelor
Dosage form TABLET
Route ORAL
Labeler Aphena Pharma Solutions - Tennessee, LLC
Application NDA022433
Marketing category NDA
Marketing start 2011-08-05
Substance TICAGRELOR
Active strength 90 mg/1
Pharmacologic classes Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022433-001 BRILINTA TICAGRELOR 90MG TABLET / ORAL AB RLD, RS 2011-07-20 N022433-002 BRILINTA TICAGRELOR 60MG TABLET / ORAL AB RLD 2015-09-03
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022433-001 8425934 2030-04-17 Drug product 2013-05-20 N022433-001 8425934*PED 2030-10-17 Pediatric extension N022433-001 10300065 2036-01-27 U-2541 2019-06-24 N022433-001 10300065 2036-01-27 U-2542 2019-06-24 N022433-001 10300065*PED 2036-07-27 Pediatric extension N022433-002 8425934 2030-04-17 Drug product 2015-09-30 N022433-002 8425934*PED 2030-10-17 Pediatric extension N022433-002 10300065 2036-01-27 U-2541 2019-06-24 N022433-002 10300065 2036-01-27 U-2542 2019-06-24 N022433-002 10300065*PED 2036-07-27 Pediatric extension
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022433-002 BRILINTA 60MG TABLET / ORAL AB RLD 2015-09-03 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022433-002 BRILINTA 60MG TABLET / ORAL AB RLD 2015-09-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-002 BRILINTA 60MG TABLET / ORAL AB RLD 2015-09-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022433-002 BRILINTA 60MG TABLET / ORAL AB RLD 2015-09-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022433-002 BRILINTA 60MG TABLET / ORAL RLD 2015-09-03 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022433-001 BRILINTA 90MG TABLET / ORAL AB RLD, RS 2011-07-20 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N022433-002 BRILINTA 60MG TABLET / ORAL AB RLD 2015-09-03 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 49 observed states.
Observed Orange Book patent history# Patent history page 1 of 27 · 1,060 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N022433-001 8425934 2030-04-17 Drug product 2013-05-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022433-001 8425934*PED 2030-10-17 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022433-001 10300065 2036-01-27 U-2541 2019-06-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022433-001 10300065 2036-01-27 U-2542 2019-06-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022433-001 10300065*PED 2036-07-27 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022433-002 8425934 2030-04-17 Drug product 2015-09-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022433-002 8425934*PED 2030-10-17 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022433-002 10300065 2036-01-27 U-2541 2019-06-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022433-002 10300065 2036-01-27 U-2542 2019-06-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022433-002 10300065*PED 2036-07-27 Pediatric extension caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022433-001 8425934 2030-04-17 Drug product 2013-05-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022433-001 8425934*PED 2030-10-17 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022433-001 10300065 2036-01-27 U-2541 2019-06-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022433-001 10300065 2036-01-27 U-2542 2019-06-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022433-001 10300065*PED 2036-07-27 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022433-002 8425934 2030-04-17 Drug product 2015-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022433-002 8425934*PED 2030-10-17 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022433-002 10300065 2036-01-27 U-2541 2019-06-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022433-002 10300065 2036-01-27 U-2542 2019-06-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022433-002 10300065*PED 2036-07-27 Pediatric extension 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 RE46276 2024-10-30 U-1936 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 RE46276 2024-10-30 U-1935 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 RE46276 2024-10-30 U-1937 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 RE46276 2024-10-30 U-1938 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 RE46276 2024-10-30 U-2988 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 RE46276 2024-10-30 U-2839 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 RE46276 2024-10-30 U-2838 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 RE46276*PED 2025-04-30 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 8425934 2030-04-17 Drug product 2013-05-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 8425934*PED 2030-10-17 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 10300065 2036-01-27 U-2541 2019-06-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 10300065 2036-01-27 U-2542 2019-06-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 10300065*PED 2036-07-27 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-002 RE46276 2024-10-30 U-1935 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-002 RE46276 2024-10-30 U-1938 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-002 RE46276 2024-10-30 U-1936 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-002 RE46276 2024-10-30 U-1937 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-002 RE46276 2024-10-30 U-2988 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-002 RE46276 2024-10-30 U-2839 Drug substance, Drug product 2017-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-002 RE46276 2024-10-30 U-2838 Drug substance, Drug product 2017-01-17 31067a03dcf5…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 7 · 248 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 M-283 2025-05-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-001 PED 2025-11-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-002 M-283 2025-05-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022433-002 PED 2025-11-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022433-001 M-283 2025-05-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022433-001 PED 2025-11-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022433-002 M-283 2025-05-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022433-002 PED 2025-11-09 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022433-001 M-283 2025-05-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022433-001 PED 2025-11-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022433-002 M-283 2025-05-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022433-002 PED 2025-11-09 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022433-001 M-283 2025-05-09 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022433-001 PED 2025-11-09 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022433-002 M-283 2025-05-09 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022433-002 PED 2025-11-09 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022433-001 I-848 2023-11-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022433-001 PED 2024-05-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022433-001 M-283 2025-05-09 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022433-001 PED 2025-11-09 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022433-002 I-848 2023-11-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022433-002 PED 2024-05-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022433-002 M-283 2025-05-09 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022433-002 PED 2025-11-09 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022433-001 I-848 2023-11-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022433-001 PED 2024-05-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022433-001 M-283 2025-05-09 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022433-001 PED 2025-11-09 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022433-002 I-848 2023-11-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022433-002 PED 2024-05-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022433-002 M-283 2025-05-09 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022433-002 PED 2025-11-09 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022433-001 I-848 2023-11-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022433-001 PED 2024-05-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022433-001 M-283 2025-05-09 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022433-001 PED 2025-11-09 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022433-002 I-848 2023-11-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022433-002 PED 2024-05-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022433-002 M-283 2025-05-09 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022433-002 PED 2025-11-09 5bbf6a4d5a75…
Additional Listing Data#
Finished product Yes
Brand name base BRILINTA
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TICAGRELOR 90 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination GLH0314RVC Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1116635 Internal RxNorm lookup 1116639 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71610-815-41 BRILINTA 5400 in 1 BOTTLE TABLET 5400 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71610-815 BRILINTA (TICAGRELOR) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC ] 2 Current NDC, 1 package rows 20240410_1547e2b6-8858-178e-e063-6394a90abb23.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join BRILINTA TICAGRELOR AstraZeneca Pharmaceuticals LP f7b3f443-e83d-4bf2-0e96-023448fed9a8 2026-05-07 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 022433 application number: NDA022433 BRILINTA TICAGRELOR Cardinal Health 107, LLC 4f9bd52a-99a7-4606-92b4-456a917aabef 2026-04-14 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 022433 application number: NDA022433 BRILINTA TICAGRELOR Aphena Pharma Solutions - Tennessee, LLC 1547e2b6-8858-178e-e063-6394a90abb23 2024-04-08 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 022433 application number: NDA022433 ndc (product): 71610-815
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 71610-815-41 71610081541 5400 TABLET in 1 BOTTLE (71610-815-41) 5400 tablet 2024-04-03 No No Current